Publication
Article
Vice President
Analysis Group
Los Angeles, CA
Professor of Medicine
University of Toronto
Toronto, ON
Manager
Research Strategy, Data Generation and
Observational Studies
Bayer Pharmaceuticals
Whippany, NJ
Manager
Analysis Group
New York, NY
HEOR Senior Project Manager
HEOR Cardio, Renal, & Vascular Diseases
Bayer AG
Wuppertal, Germany
Professor of Medicine
Epidemiology, and Clinical & Translational Science
Associate Professor of Epidemiology
University of Pittsburgh
Pittsburgh, PA
Staff Physician, Renal Section
VA Pittsburgh Healthcare System
Pittsburgh, PA
Executive Director
Research Strategy, Data Generation
and Observational Studies
Bayer Pharmaceuticals
Whippany, NJ
The Fred Hatch Professor of Medicine
Department of Medicine
Division of Nephrology
University of Tennessee Health Science Center
Memphis, TN
LEDa[LEGOS]
Université Paris-Dauphine
Paris, France
Project leader, HEOR
Cardio, Renal, & Vascular Diseases
Bayer AG
Berlin, Germany
Vice President
Health Economics and Outcomes Research
Creativ-Ceutical
Paris, France
RAND Professor of Health Services Research
Deputy Director
Primary Care Unit
Department of Public Health and Primary Care
University of Cambridge
Cambridge, UK
Associate Director
Science
Aetion
Boston, MA
HEOR Principal
Creativ-Ceutical
Kraków, Poland
Director
University of North Carolina Kidney Center
Chapel Hill, NC
Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC
Senior Outcomes Data Expert
Integrated Evidence Generation
& Business Innovation
Bayer AG
Berlin, Germany
Director
Research Strategy, Data Generation
and Observational Studies
Bayer Pharmaceuticals
Whippany, NJ
Manager
Analysis Group
Los Angeles, CA
Professor and Dean, School of Pharmacy
University of Washington
Seattle, WA
Senior Principal
Real World Solutions
IQVIA
Cambridge, MA
Senior Analyst
Analysis Group
New York, NY
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
EMPLOYMENT
Employee of Analysis Group, a consulting
company that has provided paid consulting
services to Bayer Pharmaceuticals, which
funded the development and conduct of this
study and manuscript
CONSULTANCIES OR PAID ADVISORY BOARDS
Boehringer Ingelheim-Lilly, Merck,
AstraZeneca, Sanofi, Mitsubishi-Tanabe,
AbbVie, Janssen, Bayer Pharmaceuticals,
Prometic, Bristol Myers Squibb, Maze,
CSL-Berhring, and Novo-Nordisk
GRANTS RECEIVED
Boehringer Ingelheim-Lilly, Merck, Janssen,
Sanofi, AstraZeneca, and Novo-Nordisk
CONSULTANCIES OR PAID ADVISORY BOARDS
Received consulting fees from faculty emeritus
at the University of Washington
EMPLOYMENT
Employee of Bayer Pharmaceuticals,
sponsor of the study
STOCK OWNERSHIP
Bayer Pharmaceuticals, sponsor of the study
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer Pharmaceuticals drug for chronic
kidney disease in patients with type 2 diabetes
approved in the United States
INSTITUTIONAL CONFLICTS OF INTEREST
Employee of Analysis Group, a consulting
company that has provided paid consulting
services to Bayer Pharmaceuticals, which
funded the development and conduct of this
study and manuscript
EMPLOYMENT
Employee of Bayer AG, sponsor of the study
STOCK OWNERSHIP
Holding stocks and stock options from Bayer
AG, sponsor of the study
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer Pharmaceuticals drug for chronic
kidney disease in patients with type 2 diabetes
approved in the United States
CONSULTANCIES OR PAID ADVISORY BOARDS
Consultant to Bayer Pharmaceuticals
EMPLOYMENT
Employee of Bayer Pharmaceuticals
STOCK OWNERSHIP
Employee of Bayer Pharmaceuticals
with stock options
INSTITUTIONAL CONFLICTS OF INTEREST
Employee of Bayer Pharmaceuticals, which
produces Kerendia (finerenone) for the
treatment of chronic kidney disease associated
with type 2 diabetes
CONSULTANCIES OR PAID ADVISORY BOARDS
Consultant for AstraZeneca, Bayer
Pharmaceuticals
HONORARIA
Honoraria for consultant work from
AstraZeneca, Bayer Pharmaceuticals
HONORARIA
Honoraria received from Bayer
Pharmaceuticals for ad boards related to
the development of an economic model
for finerenone
CONSULTANCIES OR PAID ADVISORY BOARDS
Previously an independent consultant
for Bayer Pharmaceuticals
EMPLOYMENT
Bayer AG employee
INSTITUTIONAL CONFLICTS OF INTEREST
Subject matter will be used to support market
launch of finerenone, which is produced by
Bayer Pharmaceuticals
HONORARIA
Honorarium from Bayer Pharmaceuticals for
participation in current manuscript
CONSULTANCIES OR PAID ADVISORY BOARDS
Consultant/Advisory Board for WL Gore,
Becton, Dickinson, and Company, Medtronic,
Humacyte, Cormedix, Akebia, Vifor-Relypsa,
Bayer Pharmaceuticals
EMPLOYMENT
Employee of Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer Pharmaceuticals drug for chronic
kidney disease in patients with type 2 diabetes
approved in the United States
EMPLOYMENT
Employee of Bayer Pharmaceuticals,
sponsor of the study
STOCK OWNERSHIP
Bayer Pharmaceuticals, sponsor of the study
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer Pharmaceuticals drug for chronic
kidney disease in patients with type 2 diabetes
approved in the United States
EMPLOYMENT
Employee of Analysis Group, a consulting
company that has provided paid consulting
services to Bayer Pharmaceuticals, which
funded the development and conduct of this
study and manuscript
CONSULTANCIES OR PAID ADVISORY BOARDS
Bayer AG supported by time to assist with
model development
EMPLOYMENT
Employee of IQVIA, which conducts research
for all of the world’s biopharma companies
INSTITUTIONAL CONFLICTS OF INTEREST
Employee of Analysis Group, a consulting
company that has provided paid consulting
services to Bayer Pharmaceuticals, which
funded the development and conduct of this
study and manuscript
report no relationships or financial interests with
any entity that would pose a conflict of interest
with the subject matter of this supplement.